Akero Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Akero Therapeutics stock have an average target of 75.86, with a low estimate of 38 and a high estimate of 109. The average target predicts an increase of 46.33% from the current stock price of 51.84.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$38	$75.86	$73	$109
Change	-26.70%	+46.33%	+40.82%	+110.26%

Analyst Ratings

The average analyst rating for Akero Therapeutics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	3	3	4	4	5	5
Buy	5	5	3	3	4	4
Hold	1	1	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	8	8	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Eliana Merle UBS	UBS	Strong Buy Maintains $42 → $109	Strong Buy	Maintains	$42 → $109	+110.26%	Jan 31, 2025
Alexandria Hammond B of A Securities	B of A Securities	Hold → Strong Buy Upgrades $35 → $63	Hold → Strong Buy	Upgrades	$35 → $63	+21.53%	Jan 30, 2025
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Maintains $46 → $96	Buy	Maintains	$46 → $96	+85.19%	Jan 28, 2025
Jonathan Woo Citigroup	Citigroup	Strong Buy Maintains $65 → $80	Strong Buy	Maintains	$65 → $80	+54.32%	Jan 28, 2025
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $56 → $73	Strong Buy	Maintains	$56 → $73	+40.82%	Jan 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-3.97

from -2.89

EPS Next Year

-4.77

from -3.97

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	-	4.93M
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-2.90	-2.52	-2.89	-2.87	-2.89	-3.97	-4.77	-4.98
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	12	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	n/a	n/a	30.5M
Avg	n/a	n/a	4.9M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2024	2025	2026
High	-3.18	-4.06	-4.11
Avg	-3.97	-4.77	-4.98
Low	-4.18	-6.12	-6.44

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.